Biography

Prof. Noriyasu Fukushima

Department of Medical Science Technology

International University of Health and Welfare, Japan


Email: fukushin@iuhw.ac.jp


Qualifications

2013 Professor, International University of Health and Welfare

2001 Doctor of Medical science, Saga Medical Graduate University

1994 Medical degree, Saga Medical University


Publications

  1. Ito Y, Kimura H, Maeda Y, Hashimoto C, Ishida F, Izutsu K, Fukushima N, Isobe Y, Takizawa J, Hasegawa Y, Kobayashi H, Okamura S, Kobayashi H, Yamaguchi M, Suzumiya J, Hyo R, Nakamura S, Kawa K, Oshimi K, Suzuki R. Pretreatment EBV-DNA copy number is predictive of response and toxicities to SMILE chemotherapy for extranodal NK/T-cell lymphoma, nasal type. Clin Cancer Res 18;4183-4190, 2012
  2. Kagami Y, Itoh K, Tobinai K, Fukuda H, Mukai K, Chou T, Mikuni C, Kinoshita T, Fukushima N, Kiyama Y, Suzuki T, Sasaki T, Watanabe Y, Tsukasaki K, Hotta T, Shimoyama M, Ogura M, The members of the Lymphoma Study Group of the Japan Clinical Oncology Group. Phase II study of cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy for newly diagnosed patients with low- and low-intermediate risk, aggressive non-Hodgkin's lymphoma: final results of the Japan Clinical Oncology Group Study, JCOG9508. Int J Hematol 96; 74-83, 2012
  3. Itamura H, Fukushima N, Kondo S, Urata C, Tanaka-Yoshimura M, Yokoo M, Ide M, Hisatomi T, Kubota Y, Sueoka E, Ichinohe T, Kimura S. Successful reduced-intensity umbilical cord blood transplant for fulminant hemophagocytic syndrome in an adult with pre-existing rheumatoid arthritis and autoimmune hemolytic anemia. Leuk Lymphoma 53; 2307-2039, 2012
  4. Azuma T, Tobinai K, Takeyama K, Shibata T, Hidaka M, Kurosawa M, Kasai M, Chou T, Fukushima N, Mukai K, Tsukasaki K, Shimoyama M, Japan Clinical Oncology Group-Lymphoma Study Group (JCOG-LSG) Phase II Study of Intensive Post-remission Chemotherapy and Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma: Japan Clinical Oncology Group Study,  JCOG9402 Jpn J Clin Oncol 42; 394-404, 2012
  5. Ureshino N, Aragane N, Nakamura T, Ide M, Mochinaga S, Fukushima N, Hayashi S, Sueoka E, Kimura S A fully integrated and automated detection system for single nucleotide polymorphisms of UGT1A1 and CYP2C19. Oncol Res 19; 111-4, 2011
  6. Urata C, Yoshimura M, Itamura H, Hisatomi T, Kubota Y, Fukushima N, Sueoka E, Kimura S Lenalidomide in combination with dexamethasone induced rhabdomyolysis in a multiple myeloma patient treated with pravastatin. Int J Hematol 94;216-7, 2011
  7. Ide M, Fukushima N, Hisatomi T, Tsuneyoshi N, Tanaka M, Yokoo M, Tomimasu R, Funai N, Sueoka E Non-germinal cell phenotype and bcl-2 expression in primary adrenal diffuse large B-cell lymphoma. Leuk Lymphoma 48; 2244-6, 2007
  8. Fukushima N, Mizuta T, Tanaka M, Yokoo M, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sueoka E Retrospective and prospective studies of hepatitis B virus reactivation in malignant lymphoma with occult HBV carrier. Ann Oncol 20; 2013-7, 2009
  9. Fukushima N, Satoh T, Sueoka N, Sato A, Ide M, Hisatomi T, Kuwahara N, Tomimasu R, Tsuneyoshi N, Funai N, Sano M, Tokunaga O, Sueoka E Clinico- pathological characteristics of p63 expression in B-cell lymphoma. Cancer Sci 97, 1050-5, 2006
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top